Question from Deputy Marie Sherlock - PQ 39643-26
Deputy Sherlock asked about the full year cost of providing reimbursement for sublingual immunotherapy. Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy Sherlock asked about the full year cost of providing reimbursement for sublingual immunotherapy. Read the HSE response.
Deputy O'Flynn asked about the reimbursement of omaveloxolone (skyclarys). Read the HSE response.
Deputy O'Flynn asked if any value-for-money assessment has been conducted regarding oversees gender affirmation surgeries. Read the HSE response.
Deputy O'Flynn asked about the clinical outcomes and costs associated with overseas procedures funded under the treatment abroad scheme. Read the HSE response.
Deputy O'Flynn asked about SCAN services in the HSE Mid West. Read the HSE response.
Deputy Doherty asked about the introduction of a single clinically-led prioritisation system for ophthalmology referrals. Read the HSE response.
Deputy O'Flynn asked if any reviews or health technology assessment has been commissioned in relation to expenditure under the treatment abroad scheme.
Deputy O'Flynn asked about the risk assessments carried out into the treatment abroad scheme. Read the HSE response.
Deputy O'Flynn asked about the continuity of clinician care in mental health services is measured as a service quality or patient safety indicator.